The Urethane Blog
Everchem Updates
VOLUME XXI
September 14, 2023
Everchem’s exclusive Closers Only Club is reserved for only the highest caliber brass-baller salesmen in the chemical industry. Watch the hype video and be introduced to the top of the league: — read more
by David Perry
NASHVILLE, Tenn. – Business is rebounding at independent sleep products manufacturer Southerland, and the producer is looking to add 10% to its workforce at all its facilities to keep up with demand.
The manufacturer is looking to expand its customer service, shipping and quality control departments, as well as increase production staffing, supervisory positions and truck drivers for Southerland Transport, its wholly owned trucking division.
Read more here: https://www.furnituretoday.com/bedding-manufacturers/as-bedding-business-rebounds-southerland-looks-to-boost-its-workforce-by-10/
June 25, 2020
Megafarma,an Azelis company,strengthens its presence for CASE in Mexico through distribution of BASF Monomers
19 June 2020
WESTPORT, CT and MEXICO CITY – Megafarma, an Azelis company, is delighted to announce that it has been authorized by BASF Monomers, a global leader in the development, production and sales of polyurethanes- to distribute their polyurethane raw materials in Mexico. The exclusive distribution agreement includes BASF’s lines of Lupranate® isocyanates and Pluracol® polyols. The agreement is effective immediately.
Highlights & rationale
- This new mandate further strengthens Azelis’ strategic acquisition of Megafarma earlier this year to expand into the Latin American CASE market.
- It leverages existing Azelis Americas CASE assets, including application labs, digital platforms, technical and market intelligence, in the Mexican market.
- The mandate is in line with Azelis’ corporate strategy of organic growth through the expansion of existing relationships with key principals into new territories.
Martin Hernandez Gutiérrez, Director General at Megafarma, an Azelis company, comments:
“Megafarma has been very successful in life sciences in Mexico and the merger with Azelis earlier this year brought us new opportunities and enabled us to enter new market segments. This new agreement with BASF is the latest example of our commitment to expand into Mexican CASE sector and become a leading distributor with unsurpassed quality, logistics and technical support for our customers and principals.”
Dan Gruber, Managing Director, New Business Development, Azelis Americas CASE, says:
“We have a longstanding relationship with BASF. In the U.S and Canada we have demonstrated organic growth via our dedicated and technically trained sales force, and our application labs have been instrumental in our joint success. We are very excited about this expansion into the Mexican market as it allows us to deliver the same value and growth that we have provided BASF Polyurethanes in the U.S and Canada.”
Rachel Miller, CASE Distribution, Monomers, North America, BASF Corporation, says:
“This collaboration with Megafarma will provide our CASE specialties customers in Mexico with the service and expertise our U.S. customers are accustomed to. Our portfolio of Lupranate® isocyanates and Pluracol® polyols can be formulated to create a variety of specialty products now in Mexico.”
Lucia Zamudio, CASE Sales Director, Megafarma, an Azelis company, adds:
“We have built a team of excellent, experienced technical sales representatives for the CASE market who are ready to pursue new business opportunities for BASF. This latest portfolio addition is complementary to our other new CASE mandates for Mexico. We have confidence that we will bring the same high quality of technical sales and service to the Mexican Urethane Market.”
June 25, 2020
Megafarma,an Azelis company,strengthens its presence for CASE in Mexico through distribution of BASF Monomers
19 June 2020
WESTPORT, CT and MEXICO CITY – Megafarma, an Azelis company, is delighted to announce that it has been authorized by BASF Monomers, a global leader in the development, production and sales of polyurethanes- to distribute their polyurethane raw materials in Mexico. The exclusive distribution agreement includes BASF’s lines of Lupranate® isocyanates and Pluracol® polyols. The agreement is effective immediately.
Highlights & rationale
- This new mandate further strengthens Azelis’ strategic acquisition of Megafarma earlier this year to expand into the Latin American CASE market.
- It leverages existing Azelis Americas CASE assets, including application labs, digital platforms, technical and market intelligence, in the Mexican market.
- The mandate is in line with Azelis’ corporate strategy of organic growth through the expansion of existing relationships with key principals into new territories.
Martin Hernandez Gutiérrez, Director General at Megafarma, an Azelis company, comments:
“Megafarma has been very successful in life sciences in Mexico and the merger with Azelis earlier this year brought us new opportunities and enabled us to enter new market segments. This new agreement with BASF is the latest example of our commitment to expand into Mexican CASE sector and become a leading distributor with unsurpassed quality, logistics and technical support for our customers and principals.”
Dan Gruber, Managing Director, New Business Development, Azelis Americas CASE, says:
“We have a longstanding relationship with BASF. In the U.S and Canada we have demonstrated organic growth via our dedicated and technically trained sales force, and our application labs have been instrumental in our joint success. We are very excited about this expansion into the Mexican market as it allows us to deliver the same value and growth that we have provided BASF Polyurethanes in the U.S and Canada.”
Rachel Miller, CASE Distribution, Monomers, North America, BASF Corporation, says:
“This collaboration with Megafarma will provide our CASE specialties customers in Mexico with the service and expertise our U.S. customers are accustomed to. Our portfolio of Lupranate® isocyanates and Pluracol® polyols can be formulated to create a variety of specialty products now in Mexico.”
Lucia Zamudio, CASE Sales Director, Megafarma, an Azelis company, adds:
“We have built a team of excellent, experienced technical sales representatives for the CASE market who are ready to pursue new business opportunities for BASF. This latest portfolio addition is complementary to our other new CASE mandates for Mexico. We have confidence that we will bring the same high quality of technical sales and service to the Mexican Urethane Market.”
June 25, 2020
Dow CFO sees additional $350M headwind to Q2 EBITDA
Jun. 24, 2020 6:57 PM ET|About: Dow Inc. (DOW)|By: Carl Surran, SA News Editor
Dow Inc. (DOW -7%) was today’s biggest loser on the Dow Jones index after President and CFO Howard Ungerleider said he expects “an additional $350M headwind” to total EBITDA in Q2 compared with current market expectations, primarily due to a delayed and slower recovery in the automotive, construction, appliance and furniture sectors.
In remarks today at the BMO Chemicals & Packaging Conference, Ungerleider said Dow saw gradual incremental gains in May from April to May with expectations for further revenue improvement in June, but the composition of sales by segment is a bit different than expected, driven by lower spending in consumer durables and big-ticket items.
The “sluggish Q2 recovery in durable consumer items has significantly impacted our Industrial Intermediates and Infrastructure operating segment… with polyurethanes having the greatest exposure to these end-markets. Going into Q2, we expected demand declines in our polyurethanes applications in the 15%-20% range.. but now believe it will be closer to the 25%-30% range,” the CFO said.
On a more upbeat note, Ungerleider found it “encouraging to see the pace of recovery beginning to accelerate in June in almost every value chain in our portfolio… Our order books and shipments for this month show that volume expectations continue to improve across all of our businesses.”
June 25, 2020
Dow CFO sees additional $350M headwind to Q2 EBITDA
Jun. 24, 2020 6:57 PM ET|About: Dow Inc. (DOW)|By: Carl Surran, SA News Editor
Dow Inc. (DOW -7%) was today’s biggest loser on the Dow Jones index after President and CFO Howard Ungerleider said he expects “an additional $350M headwind” to total EBITDA in Q2 compared with current market expectations, primarily due to a delayed and slower recovery in the automotive, construction, appliance and furniture sectors.
In remarks today at the BMO Chemicals & Packaging Conference, Ungerleider said Dow saw gradual incremental gains in May from April to May with expectations for further revenue improvement in June, but the composition of sales by segment is a bit different than expected, driven by lower spending in consumer durables and big-ticket items.
The “sluggish Q2 recovery in durable consumer items has significantly impacted our Industrial Intermediates and Infrastructure operating segment… with polyurethanes having the greatest exposure to these end-markets. Going into Q2, we expected demand declines in our polyurethanes applications in the 15%-20% range.. but now believe it will be closer to the 25%-30% range,” the CFO said.
On a more upbeat note, Ungerleider found it “encouraging to see the pace of recovery beginning to accelerate in June in almost every value chain in our portfolio… Our order books and shipments for this month show that volume expectations continue to improve across all of our businesses.”
Everchem Updates Archive 
Sign Up for Email Updates